Egypt’s Hepatitis C Program: A Model for Africa’s Health Initiatives
The article from the Africa CDC website, titled "Egypt's Hepatitis Programme Becomes a Model for African Countries," highlights Egypt's successful hepatitis C elimination program, which se...
Maturity Level 3 in Medicines Regulation in Senegal and Rwanda
The article from the World Health Organization (WHO) titled "Senegal and Rwanda achieve WHO Maturity Level 3 in medicines regulation" emphasizes the importance of achieving Maturity Level 3 (ML3) in medicines regulation, highlighting several key points and implications, both locally and globally....
Advancing the 95-95-95 Targets: A Roadmap to End AIDS by 2030
The UNAIDS document, Progress towards the 95–95–95 HIV Testing, Treatment, and Viral Suppression Targets, outlines a critical framework in the global fight against HIV/AIDS. The 95-95-95 HIV target...
Infection Control and Disease Surveillance in Africa
The topic of National borders as a critical frontline in containing deadly infections is increasingly significant for public health initiatives. The Africa CDC plays a crucial role in addressing infection prevention and control measures linked to these borders. Their approach emphasises the neces...
CMS Price Negotiations: Bridging the Gap in US Drug Pricing
A recent research article published in JAMA analyzed the impact of CMS price negotiations and the disparities in medicine pricing between the US and other countries. Let's explore the significant implications of the CMS price negotiations and their efficacy in addressing this issue.
Impact o...
Access to Anti-Obesity Medication for Medicare and Medicaid
The Biden administration's proposal to expand anti-obesity medication coverage under Medicare and Medicaid focuses on improving access ...
